A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations-Reference-Cited by-同舟云学术

A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations

Published:2014-05 Issue:3 Volume:48 Page:393-403
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Oishi Masayo,Hiro Shintaro,Matsuoka Nobushige,Hotta Shinichi,Ono Ryosuke,Mori Yuko,Takenaka Nobuko,Uchikawa Yoko,Arakawa Akio,Yuasa Hirotoshi,Ishibashi Taro,Miyoshi So,Hirai Kanji,Kawai Norisuke

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479013517892.pdf

Reference22 articles.

1. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–1320.

2. Kurose K, Sugiyama E, Saito Y. Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2012;27:9–54.

3. Myrand SP, Sekiguchi K, Man MZ, et al. Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther. 2008;84:347–361.

4. Man M, Farmen M, Dumaual C, et al. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol. 2010;50:929–940.

5. Tominaga T, Ando Y, Nagai N, et al. Balancing societal needs and regulatory certainty: the case study of peramivir in Japan. Clin Pharmacol Ther. 2013;93:342–344.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries: Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?;The Journal of Clinical Pharmacology;2024-01-11

2. Comparison of Pharmacokinetics of the GalNAc-Conjugated Antisense Oligonucleotide GSK3389404 in Participants with Chronic Hepatitis B Infection across the Asia-Pacific Region;Antimicrobial Agents and Chemotherapy;2023-01-24

3. Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo;Clinical Pharmacology & Therapeutics;2022-04-17

4. Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study;Clinical and Translational Science;2021-01-27

5. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data;Therapeutic Innovation & Regulatory Science;2021-01-03